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Liver I/R procedure and drug treatment I/R experimental protocol is depicted in Figure 1 . We randomly assigned 6 animals for vehicle-or drugtreated sham groups and 8 animals for vehicle-or drug-treated I/R groups. Mice were anestheti ed with ketamine (100 mg/kg, i.m.) and xyla ine (10 mg/kg, i.m.). The body temperature of mice was maintained at 37°C throughout the anesthesia process. The left branches of the portal vein and hepatic artery were clamped to induce complete ischemia of the median and left lobes of the liver. The right lobes remained perfused to prevent venous congestion of the intestine. After 60 min of ischemia, the clamp was removed to allow reperfusion for 0 (immediately after declamping), 1, 5 and 24 h. Sham-operated mice were prepared in a similar manner; however, a clip was not placed on the vasculature leading to the median and left lobes. After I/R injury, mice were sacri iced and blood from the inferior vena cava and liver tissue was collected. Liver tissue was analy ed immediately by histological staining of sections from the left lobe. The remaining portions of the median and left lobes were lash fro en in liquid nitrogen and kept at -75°C until biochemical analyses were performed.
MLT was dissolved in 5% ethanol in saline and administered (10 mg/kg of bw, i.p.) 15 min prior to ischemia and again directly before reperfusion. The dosage and timing of MLT administration were selected based on a previous study [17] . CQ dissolved in phosphate-buffered saline (P S) was injected (60 mg/kg of bw, i.p.) 1 h prior to ischemia. Rapa was dissolved in dimethyl sulfoxide (DMSO) and diluted with P S to a inal concentration of 1% DMSO in P S. Rapa was injected (1 mg/kg of bw, i.p.) 1.5 h prior to ischemia. In vehicle-treated sham or I/R mice, 5% ethanol-saline, P S, or 1% DMSO-P S were administered in the same volume and route as the respective drug treatments. No effects of these vehicles on liver function were detected. The dosage and timing of injections of CQ and Rapa were determined based on previous studies [18, 19] as well as preliminary investigations in our laboratory. Fig. 1 . Schematic presentation of the experimental procedures. Protocol 1-Time course of autophagy changes during liver I/R After 60 min of ischemia, the clamp was removed to allow reperfusion for 0 (immediately after declamping), 1, 5 and 24 h. Protocol 2-Effects of MLT on hepatocellular damage and autophagic lux during liver I/R MLT was administered 15 min prior to ischemia and directly before reperfusion. Mice were sacri iced after 5 h of reperfusion. Protocol 3-Effects Rapa on MLT-induced protection during liver I/R Rapa was injected 1.5 h prior to ischemia and MLT was administered 15 min prior to ischemia and directly before reperfusion. Mice were sacri iced after 5 h of reperfusion. Protocol 4-Effects of CQ on autophagic lux during liver I/R CQ was injected 1 h prior to ischemia and mice were sacri iced after 5 h of reperfusion.
Serum aminotransferase activities
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were measured with ChemiLab ALT and AST assay kit (I DLab Co., iwang, Korea), respectively.
Hematoxylin and eosin (H&E) staining and terminal dUTP nick-end labeling (TUNEL) assay
Liver specimens were ixed in 10% buffered formalin, embedded in paraf in, and stained with H E. The stained sections were blindly examined using a light microscope (Olympus CKX41, Olympus Optical Co., Tokyo, Japan). We have utili ed the criteria reported by Su uki et al. [20] . In this classi ication, 3 liver injury indices-sinusoidal congestion (score 0 4), hepatocyte necrosis (score 0 4), and ballooning degeneration (score 0 4)-are graded for a total score of 0 12. Apoptotic cells were detected by T NEL staining with a commercially available kit (ApopTag ® In Situ Apoptosis Detection Kits, Millipore, illerica, MA, SA). Apoptosis of hepatocytes in liver sections was quantitated by counting the number of T NEL-positive cells in random microscopic high-power elds (x100).
Caspase-3 activity
Caspase-3 activity was measured using a luorogenic peptide substrate, N-acetyl-Asp-lu-al-Asp-7-amino-4-tri luoromethyl-cumarine (DE D-AFC; io-Mol, Plymouth Meeting, PA, SA). A 30 g sample of the liver cytosolic protein was incubated in a buffer containing 30 mM N-[2-hydroxyethyl] pipera ine-N -[2-ethanesulfonic acid] (HEPES), 0.3 mM EDTA, 100 mM NaCl, 0.15% Triton X-100 and 10 mM dithiothreitol. The samples were incubated at room temperature for 15 min. The caspase reaction was then initiated by adding 200 M DE D-AFC, and the resulting mixture was incubated at 37°C. The change in luorescence (excitation at 400 nm and emission at 490 nm) was monitored after 120 min.
Hepatic lipid peroxidation and GSH/GSSG ratio
The steady-state level of malondialdehyde (MDA), an end-product of lipid peroxidation, was determined in liver tissues by measuring the levels of thiobarbituric acid-reactive substances [21] . Total levels of hepatic glutathione were determined by measuring yeast-glutathione reductase, 5,5 -dithio-bis(2-nitroben oic acid), and nicotinamide adenine dinucleotide phosphate (NADPH) in liver homogenates after precipitation with 1% picric acid. Levels of oxidi ed glutathione ( SS ) were determined by the same method but in the presence of 2-vinylpyridine. The levels of reduced glutathione ( SH) were calculated as the difference between the total levels of glutathione and SS [22] .
Western blot analysis
Liver tissue protein lysates were prepared using radioimmunoprecipitation assay buffer, separated in SDS-PA E gels, and transferred to polyvinylidene di luoride membranes as previously described [23] . Western blotting was performed using primary antibodies and horseradish peroxidase-conjugated secondary antibodies suitable for each primary antibody. The WEST-one Western lot Detection System (iNtRON iotechnology Inc., Seongnam, Korea) was used for detection according to the manufacturer s instructions. Intensities of the immunoreactive bands were determined using TotalLab TL120 software (I DLab Nonlinear Dynamics Co. Ltd., Newcastle, K). -Actin was used as a loading control and protein levels were normali ed relative to corresponding -actin band intensity.
Transmission electron microscopy (TEM)
Liver tissues were ixed in 4% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M P S. Tissues were then ixed with 1% osmium tetroxide, serially dehydrated in ethyl alcohol (50% to 100%), stained with 0.5% uranyl acetate, and embedded in Poly/ ed 812 resin (Pelco, Redding, CA, SA) followed by polymeri ation. Samples were sectioned using an ltracut S (Leica, Wet lar, ermany), and ultrathin sections were stained with 1% uranyl acetate and 0.2% lead citrate. Autophagic vacuoles were observed from blinded samples using a transmission electron microscope (JEM-1010, JEOL, Tokyo, Japan). In randomly selected ields, we captured 4 non-repeating micrographs for each liver sample (n=3-4 per group) and the area of one such micrograph was regarded as the unit area. The numbers of autophagic vacuoles per unit area (400 m 2 ) in each sample were counted. signi icantly immediately after reperfusion (148.3% of sham), but were restored to basal levels after 1 h of reperfusion and maintained thereafter with reperfusion for 24 h (Fig. 2 ) . To evaluate autophagic lux in the liver, we evaluated changes in levels of LC3-I and LC3-II and protein expression of SQSTM1/p62, which is a polyubiquitin-binding protein known to be sequestered and degraded during autophagy. As shown Fig. 2C , the LC3-II/LC3-I ratio was similar to those of sham-operated animals at the end of the ischemic period and immediately after reperfusion, and was signi icantly increased after reperfusion for 1 and 5 h, but gradually declined after reperfusion for 24 h (707.0% of sham, 583.1% of sham, and 242.5% of sham, respectively). In contrast, the expression of SQSTM1/p62 was signi icantly decreased after reperfusion for 1 and 5 h and gradually restored after reperfusion for 24 h (71.9% of sham, 72.1% of sham, and 90.3% of sham, respectively) (Fig. 2D) .
Effects of MLT on hepatocellular damage and oxidative stress during liver I/R
ecause the most signi icant changes in LC3-II/LC3-I ratio, SQSTM1/p62 protein expression, and the most severe hepatocellular damage were noted after 5 h of reperfusion, increase in LC3-II/LC3-I ratio (713.8% of sham). On the other hand, SQSTM1/p62 protein expression decreased signi icantly after reperfusion for 5 h compared to sham-operated animals (28.0% of sham). MLT attenuated this decrease (120.1% of sham), indicating inhibition of autophagic lux by MLT (Fig. 4 ) ; however, protein expression of beclin-1 was not affected by either I/R or treatment with MLT (Fig. 4C) .
To con irm our Western blot results, autophagosomes and related autophagic vacuoles were observed by TEM. Autophagosomes are characteri ed by double-and multiplemembrane structures containing cytoplasm or undigested organelles including mitochondria. Conversely, autolysosomes are identi ied as single-membrane structures with remnants of cytoplasmic components. Compared with the basal level of autophagic vacuoles in shamoperated animals (1.8 0.3), the number of autophagic vacuoles increased following liver I/R (5.8 0.8), which was attenuated by MLT (2.9 0.4) (Fig. 4D) .
LC3 is conjugated to phosphatidylethanolamine (PE) by a sequence of ubiquitinationlike reactions that involves the Atg4 and Atg7 proteases as well as a different E2 analogue (Atg3). The lipidated form of LC3 is associated with the autophagosomal membrane, and thus we also assessed two hallmarks of the Atg machinery by measuring the protein expression of Atg3 and Atg7. After reperfusion for 5 h, the protein expression of Atg3 was signi icantly increased compared with sham-operated animals (257.9% of sham), which was not affected by MLT. In addition, Atg7 protein expression was not affected by I/R or treatment with MLT ( Fig. 4E and 4F ).
Effects of MLT on autophagic signaling during liver I/R
To elucidate the mechanisms of MLT inhibitory effects on autophagy during liver I/R in vivo, we investigated the involvement of a mTOR-dependent pathway and the calpain system, which is independent of mTOR. The level of p-mTOR protein expression was signi icantly decreased by I/R (56.9% of sham) and this decrease was attenuated by MLT (97.6% of sham) (Fig. 5A) . The phosphorylation status of 4E-P1 (Ser 65) and 70S6K (Thr 389), two well-known downstream phosphorylation targets of mTOR, was signi icantly decreased in livers subjected to I/R compared to sham-operated animals (23.5% of sham and 51.5% of sham, respectively). These decreases were attenuated by MLT (88.7% of sham and 107.3% of sham, respectively) ( Fig. 5 and 5C ). The protein expression of calpain 1 and calpain 2 was signi icantly increased after reperfusion for 5 h (164.0% of sham and 256.1% of sham, respectively), which was not affected by MLT (Fig. 5D and 5E ).
Effects of Rapa on MLT-induced protection during liver I/R
Rapa is a potent inducer of autophagy in various cell lines that functions by suppressing mTORC1, which in turn leads to a reduction in the phosphorylation of the downstream effectors 4E-P1 and 70S6K. Therefore, we utili ed Rapa to con irm the mTOR-dependent inhibition of autophagy by MLT and its possible contribution to amelioration of liver damage triggered by I/R. First, we con irmed the effect of Rapa by Western blot for p-mTOR, p-4E-P1 and p-70S6K. In the presence of Rapa, phosphorylation of mTOR, 4E-P1 and 70S6K was signi icantly lower compared to MLT-treated I/R animals (64.1% of MLT+I/R, 30.7% of MLT+I/R and 33.1% of MLT+I/R, respectively) (Fig. 6 , 6C, and 6D ). In addition, treatment with Rapa restored autophagic lux as determined by the LC3-II/LC3-I ratio and protein expression of SQSTM1/p62. Interestingly, accumulation of LC3-II and the increase in SQSTM1/p62 induced by MLT treatment was abolished by Rapa after reperfusion for 5 h (72.7% of MLT+I/R and 70.8% of MLT+I/R, respectively) ( Fig. 6E and 6F) ; however, Rapa did not affect the protein levels of beclin-1 (Fig. 6 ) . Finally, Rapa reversed the protective effects of MLT against I/R-induced hepatocellular damage as indicated by the signi icantly higher serum ALT activity compared to MLT-treated I/R animals (MLT + I/R; 3943.6 ± 400.4 /L vs. Rapa + MLT + I/R; 6877.9 ± 112.1 /L) (Fig. 6H ).
Discussion
The pattern changes, functional role, and detailed mechanisms of autophagy in I/R remain controversial. Similarly, it is unclear whether autophagy is hepatoprotective or prodeath in liver I/R injury, and how it varies according to the type, magnitude, and timing of the stimulus. It was recently reported that inhibition of autophagy by chloroquine reduces liver I/R injury at the early phase (0-6 h after reperfusion), but contributes to worsened injury during the late phase (24-48 h after reperfusion) [24] .
We initially performed a time course study using 60 min of moderate ischemia with various lengths of reperfusion and measured expression of autophagy-related proteins. Despite the differences in their relative role in the regulation of autophagy, both beclin-1 and LC3 represent core autophagy proteins. eclin-1 is an upstream signaling mediator of autophagosome nucleation that interacts with a multi-protein regulatory signalosome, whereas LC3 acts downstream of these events by participating in elongation of autophagosomes [25] . In the present study, the level of beclin-1 protein expression increased immediately after reperfusion and recovered to basal levels 1 h after reperfusion, which were maintained up to 24 h of reperfusion. On the other hand, ischemia for 60 min did not affect the LC3-II/LC3-I ratio, while reperfusion for 1 and 5 h resulted in a signi icant increase in the LC3-II/LC3-I ratio. This pattern was similar to the results of serum ALT activity, suggesting that increased autophagy is linked to liver damage and dysfunction during I/R.
Oxidative stress may affect autophagy through multiple mechanisms. During starvation, hydrogen peroxide directly oxidi es HsAtg4 and inhibits its cysteine protease activity, resulting in increased LC3 lipidation and autophagy in cancer cells [26] . Other scenarios such as opening of the mitochondrial permeability transition pore and induction of ER stress have been suggested as mediators of oxidative stress-induced autophagy [27] . Previously, anti-oxidant N-2-mercaptopropionyl glycine was shown to confer cardioprotection through blockage of the autolysosome formation step [28] . Moreover, MLT suppresses formation of oxygen-glucose deprivation-induced autolysosomes in endothelial cells by inhibiting peroxynitrite formation [29] , and also protects against oxidative stress-related diseases such as cerulein-induced pancreatitis by reducing the abundance of autophagosomes [30] . In the present study, MLT exerted a strong protective effect against I/R-induced hepatocellular damage and oxidative stress. Moreover, MLT inhibited the increase in autophagic lux as indicated by the increased LC3-II/LC3-I ratio and SQSTM1/p62 protein expression. These results were supported by TEM images showing that MLT attenuates the increased number of autophagic vacuoles, which correlated with our Western blot results. Interestingly, MLT had similar effects on autophagic lux compared with CQ, a lysosomal protease inhibitor that interferes with lysosomal degradation (data not shown). Turnover of LC3-II in the presence of CQ indicates the delivery of LC3-II to lysosomes for degradation and completion of autophagic lux [31] . In the present study, CQ further increased the LC3-II/LC3-I ratio and blocked SQSTM1/p62 degradation, re lecting the increase of autophagic lux during I/R. In addition, CQ treatment attenuated the increase in serum ALT activity.
To the best of our knowledge, this is the irst study demonstrating that the potent antioxidant MLT attenuates I/R-induces hepatocellular damage by inhibiting autophagic lux. However, Zaouali et al. [16] reported that autophagy is impaired during cold I/R injury and that a cocktail of MLT and trimeta idine improves steatotic liver graft preservation through activation of autophagy. These differences in results may be due to the different I/R models (warm vs. cold) and liver types (normal vs. steatotic) employed in the two studies.
LC3 is synthesi ed as proLC3 and is cleaved by Atg4 to produce LC3-I, which contains an exposed C-terminal ly. LC3-I is then activated by Atg7, transferred to the E2-like en yme Atg3, and inally conjugated to PE, where it is then designated as LC3-II [32] . In rat notochordal cells, high levels of glucose evoke ROS-induced autophagy involving up-regulation of Atg3 and Atg7 [33] . Moreover, a deleterious role of Atg7 has been reported due to its presence upstream of neuronal death pathways after hypoxic-ischemic injury [34] , whereas studies of Atg3 in ischemic disease are very limited. In the present study, Atg3 protein expression signi icantly increased after reperfusion for 5 h, while Atg7 protein expression was not affected by I/R. In addition, MLT did not affect protein levels of Atg3 and Atg7. Considering the complexity of Atg machinery during autophagic lux, the precise cross-talk between MLT and the LC3 lipidation should be studied further.
The underlying mechanisms regulating autophagy have been widely studied, with mTOR, intracellular Ca 2+ , calmodulin-dependent protein kinase kinase-, and 5' AMPactivated protein kinase having been explored as upstream regulatory mechanisms of autophagy [35] . MLT has been shown to activate mTOR signaling and prevent ischemic brain injury and methamphetamine-induced neurotoxicity [36, 37] . In this study, mTOR activity was decreased in livers subjected to I/R as demonstrated by decreased phosphorylation of mTOR, 4E-P1 and 70S6K, while MLT treatment attenuated this decrease. In order to further examine the association of mTOR-mediated autophagy suppression and hepatoprotective effects exerted by MLT, we utili ed Rapa, which induces autophagy by binding with FK P1 to speci ically inhibit the mTOR complex 1 [19] . Treatment with Rapa alone augmented increased serum ALT activity compared to I/R animals, showing that excessive autophagy activation during I/R could be detrimental. Furthermore, pretreatment with Rapa abrogated the protective effects of MLT against I/R injury. -dependent cellular events including cytokine processing and apoptosis/necrosis [39] . There are several reports of the MLT-mediated in luence on intracellular concentrations of free Ca 2+ and neuroprotection afforded by inhibition of Ca 2+ -regulated signaling cascades such as mitochondrial and ER pathways [40] . In addition, MLT alleviates neuronal cell death by reducing calpain expression/activity, while it increases the protein levels of the endogenous calpain inhibitors calpastatin [41, 42] . In our study, protein expression of calpain 1 and calpain 2 in the liver were increased by I/R, but were not affected by treatment with MLT. Collectively, our data demonstrate that MLT inhibits autophagy through an mTOR-dependent mechanism.
In summary, our results suggest that increased autophagic lux might contribute to liver injury during I/R in vivo. Moreover, MLT ameliorates I/R-induced hepatocellular damage and inhibits autophagy by activation of mTOR signaling. These indings present a novel therapeutic potential of MLT by pharmacological modulation of autophagy for ischemic liver disease.
